Pfizer sells off Capsugel Capsule Maker Business for $2.38 Billion

This is the big year that Lipitor comes off patent and thus a loss of revenue is anticipated at generics come on line. There could be additional companies spun off in time as the article reports. BD

Pfizer, which recently told Wall Street it planned to slim down its business, said it would sell off capsule-maker Capsugel to the private equity group KKR for nearly $2.38 billion.

Capsugel makes a variety of gel capsules for the pharmaceutical and supplement industries. It produced more than 180 billion capsules last year, generating $750 million in revenue, according to a statement issued by Pfizer.

The capsule-maker is located in Peapack and Gladstone and employs 2,850 around the world but has fewer than 50 workers in New Jersey.